Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$PTCT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $1.01 up 221.69% YoY • Reported revenue of $360.52M up 101.55% YoY • PTC Therapeutics expects full-year 2026 total revenue of $1.18 to $1.28 billion, with the company raising its full-year product revenue guidance to a range of $850 to $950 million.

Price since post

Full Details

Advertisement|Remove ads.